Abstract:Background: There is emerging evidence that current 8th edition of the American Joint Committee staging system is not sensitive enough to predict parotid gland carcinoma (PGC) survival outcomes. Purpose: The present study aimed to analyze pathological nodal factors related to survival and treatment outcomes in a cohort of patients surgically treated with PGC. Study design, setting, sample: We performed a retrospective cohort study of consecutive patients surgically treated with PGC at the authors' institution from January 1993 to December 2018. The inclusion criteria were as follows: confirmed high-grade parotid gland malignancy on histopathology first surgical treatment of the parotid cancer with neck dissection with curative intent at the study clinic; and sufficient data for review. The exclusion criteria were previous treatment in another institution, low-grade carcinomas, cases where neck dissection was not performed, incurable local disease and distant metastases at the time of first diagnosis, and patients lost to follow-up. Predictor variable: Predictor variable comprised pathological nodal factors grouped as the number of cervical node metastases, extranodal extension (ENE), largest diameter of nodal metastasis, and involvement of parotid lymph nodes. Main outcome variables: Outcomes evaluated were overall survival (OS), disease-specific survival (DSS), recurrence-free survival (RFS), locoregional recurrence-free survival, and distant metastasis-free survival (DMFS). OS was calculated from the day of biopsy or definitive surgery to the last known hospital follow-up date or the date of death found in the hospital records or social security data. DSS was calculated from the day of biopsy or definitive surgery until the last known follow-up or death from PGC reported in the patient record. Patients who died from causes other than the disease being studied are not counted in this measurement. Treatment outcome was evaluated through the occurrence of locoregional relapse of the disease or development of distant metastases. RFS was defined as the time from the date of biopsy or definitive surgery to the date of locoregional recurrence free survivalor DMFS reported in the patient record. Covariates: Covariates were composed of a set of heterogeneous variables grouped into the following categories: demographic, pathologic, and clinical. Analyses: Unadjusted and adjusted hazard ratios for each variable were calculated with univariate and multivariable Cox regression. The tatistical significance was defined at a P value of < .05. Results: The cohort of 112 patients included 62 males (55%) and 50 (45%) females. The mean age of the patients was 60.52 ± 15.22 years. The median follow-up time was 59 months (3-221 months). Adenoid cystic carcinoma was the most common tumor type with the incidence of 45%. Cumulative OS for the 5-and 10-year follow-up period was 75 and 61%, respectively. Locoregional recurrences occurred with 27 patients (24%), distant metastases occurred with 25 patients (22%), and both were diagnosed with 5 patients (6%). The number of metastatic nodes was the most important nodal prognostic factor related to OS (P = .02; HR = 2.67; CI = 0.03-6.35), DSS (P = .011; HR = 2.55; CI = .61-6.83), and DMFS (P = .005; HR = 2.85; CI = 0.12-4.76). The presence of pathological parotid nodes was associated with poorer RFS (P = .015; HR = 3.45; CI = 0.25-6.02). Conclusion and relevance: The number of metastatic lymph nodes, instead of ENE and largest nodal diameter, was the contributing factor associated with survival and treatment outcomes of surgically treated patients with high-grade PGC. Since the main function of staging system is to predict outcomes, the significance of ENE and nodal dimension in salivary gland cancer staging system requires further clarification. An important finding in the present study was that the presence of positive parotid lymph nodes was associated to locoregional treatment failure.

Number of positive lymph nodes affects oncologic outcomes in cN0 mucoepidermoid carcinoma of the major salivary gland

Anatomic Extent of Lymph Node Metastases As an Independent Prognosticator in Node-Positive Major Salivary Gland Carcinoma: A Study of the US SEER Database and a Chinese Multicenter Cohort.

The Number and Ratio of Positive Lymph Nodes Are Independent Prognostic Factors for Patients with Major Salivary Gland Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset.

Positive lymph nodes predict distant metastasis of salivary duct carcinoma after postoperative radiotherapy

Number and ratio of metastatic lymph nodes impacts the prognosis of submandibular gland cancer

Prognostic Impact of the Number of Lymph Nodes Examined in Different Stages of Colorectal Mucinous Adenocarcinoma.

Cervical Lymph Node Metastatic Status and Adjuvant Therapy Predict the Prognosis of Salivary Duct Carcinoma

Prognostic Factors in Primary Salivary Gland Mucoepidermoid Carcinoma: an Analysis of 376 Cases in an Eastern Chinese Population

Prognostic Importance of Numbers of Retrieved Lymph Nodes and Positive Lymph Nodes for Ampulla of Vater Cancer (AVC) in 2347 Patients from the Surveillance, Epidemiology, and End Results (SEER) Database.

The Number of Positive Lymph Nodes Instead of Extranodal Extension and Nodal Diameter is an Independent Predictor of Survival and Treatment Outcome of High-Grade Parotid Gland Carcinoma

Predictive index for lymph node management of major salivary gland cancer.

[Analysis of risk factors and construction of nomogram model for local lymph node metastasis in salivary gland mucoepidermoid carcinoma]

Impact of the Number of Harvested Lymph Nodes on Long-term Survival in Node-Negative Non-small Cell Lung Cancer: Based on Clinical Stage but Not Pathological Stage

Number of positive lymph nodes better predicts survival for oral cavity cancer

Prognostic Analysis and Establishment of a Nomogram in Patients with Myoepithelial Carcinoma of the Salivary Gland: A Population‐based Study

Significance of the Number of Positive Lymph Nodes and Size of Primary Lesion for Prognosis of Resected Non-Small Cell Lung Cancer

Increased expression of MUC1 predicts poor survival in salivary gland mucoepidermoid carcinoma

Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0

Incorporation Of The Number Of Positive Lymph Nodes Leads To Better Prognostic Discrimination Of Node-Positive Early Stage Cervical Cancer

Number of Negative Lymph Nodes As a Prognostic Factor in Esophageal Squamous Cell Carcinoma

Impact of the Number of Resected Lymph Nodes on Postoperative Survival of Patients with Node-Negative Oesophageal Squamous Cell Carcinoma.